Monounsaturated fatty acid for preventing and/or treating skin complexion imperfections

Patent metadata

Field	Value
Publication number	US-9730905-B2
Application number	US-201113883700-A
Country	US
Kind code	B2
Filing date	Nov 3, 2011
Priority date	May 11, 2010
Publication date	Aug 15, 2017
Grant date	Aug 15, 2017

Abstract

The invention relates to the oral or nutraceutical cosmetic use of an effective amount of at least one monounsaturated fatty acid, a salt thereof and/or an ester thereof, as an active agent for treating and/or preventing skin complexion imperfections.

First claim

The invention claimed is:

1. A cosmetic method for revealing the radiance of the skin complexion comprising orally administering an effective amount of at least one monounsaturated fatty acid, a salt thereof and/or an ester thereof to a subject in need thereof, said complexion being affected by excessive secretion of sebum.

2. The method of claim 1 , in which the skin is the skin of the face, the neck and/or the neckline.

3. The method of claim 1 , in which said monounsaturated fatty acid, salt thereof and/or ester thereof is used in an isolated form or in a plant extract.

4. The method of claim 1 , in which the monounsaturated fatty acid, salt thereof and/or ester thereof is used in an oral composition, and in which the content of said monounsaturated fatty acid, salt thereof and/or ester thereof is such that the daily dose ranges from 0.5 to 2500 mg/day.

5. The method of claim 1 , in which said monounsaturated fatty acid is petroselinic acid.

6. The method of claim 5 , in which said petroselinic acid is used in the form of an oil from an Umbellifera plant or from Geranium sanguineum.

7. The method of claim 6 , in which said Umbellifera plant oil is chosen from the seed oils of coriander, chervil, carrot, celery, cumin, caraway, parsley and dill, and mixtures thereof.

8. The method of claim 1 , in which said monounsaturated fatty acid is used in combination with at least one additional cosmetic active agent, chosen from vitamin B3, B5, B6, B8, C, or E, carotenoids, curcuminoids, niacin, flavonoids, one or more divalent mineral cations, bacteria or bacterial extracts derived from non-photosynthetic, filamentous bacteria, and probiotic microorganisms.

9. The method of claim 8 , in which said probiotic microorganism is chosen from microorganisms of the genus Lactobacillus or Bifidobacterium.

10. The method of claim 8 , in which the probiotic microorganism is a lactic acid bacterium.

Assignees

• Gueniche Audrey
• Castiel Isabelle
• Oreal
• Nestec Sa

Inventors

• Gueniche Audrey
• Castiel Isabelle

Classifications

• A61P17/00

  Drugs for dermatological disorders · CPC title

• A61K31/341

  not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine · CPC title

• A61K8/361

  Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof · CPC title

• A23V2002/00

  Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title

• A61K35/741

  Probiotics (probiotic yeast, e.g. saccharomyces A61K36/06) · CPC title